Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease
- PMID: 25368032
- PMCID: PMC4267987
- DOI: 10.1161/HYPERTENSIONAHA.114.03936
Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease
Abstract
We sought to investigate the role of aldosterone as a mediator of disease and its relationship with the counter-regulatory natriuretic peptide (NP) system. We measured plasma aldosterone (n=1674; aged≥45 years old) in a random sample of the general population from Olmsted County, MN. In a multivariate logistic regression model, aldosterone analyzed as a continuous variable was associated with hypertension (odds ratio [OR]=1.75; 95% confidence interval [CI]=1.57-1.96; P<0.0001), obesity (OR=1.34; 95% CI=1.21-1.48; P<0.0001), chronic kidney disease (OR=1.39; 95% CI=1.22-1.60; P<0.0001), central obesity (OR=1.47; 95% CI=1.32-1.63; P<0.0001), metabolic syndrome (OR=1.41; 95% CI=1.26-1.58; P<0.0001), high triglycerides (OR=1.23; 95% CI=1.11-1.36; P<0.0001), concentric left ventricular hypertrophy (OR=1.22; 95% CI=1.09-1.38; P=0.0007), and atrial fibrillation (OR=1.24; 95% CI=1.01-1.53; P=0.04), after adjusting for age and sex. The associations with hypertension, central obesity, metabolic syndrome, triglycerides, and concentric left ventricular hypertrophy remained significant after further adjustment for body mass index, NPs, and renal function. Furthermore, aldosterone in the highest tertile correlated with lower NP levels and increased mortality. Importantly, most of these associations remained significant even after excluding subjects with aldosterone levels above the normal range. In conclusion, we report that aldosterone is associated with hypertension, chronic kidney disease, obesity, metabolic syndrome, concentric left ventricular hypertrophy, and lower NPs in the general community. Our data suggest that aldosterone, even within the normal range, may be a biomarker of cardiorenal and metabolic disease. Further studies are warranted to evaluate a therapeutic and preventive strategy to delay the onset and progression of disease, using mineralocorticoid antagonists or chronic NP administration in high-risk subjects identified by plasma aldosterone.
Keywords: aldosterone; biomarkers; chronic kidney disease; hypertension; natriuretic peptides; obesity.
© 2014 American Heart Association, Inc.
Conflict of interest statement
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4267987/bin/nihms633497f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4267987/bin/nihms633497f2.gif)
Comment in
-
Mineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome.Hypertension. 2015 Jan;65(1):41-2. doi: 10.1161/HYPERTENSIONAHA.114.04117. Epub 2014 Nov 3. Hypertension. 2015. PMID: 25368029 No abstract available.
Similar articles
-
Mineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome.Hypertension. 2015 Jan;65(1):41-2. doi: 10.1161/HYPERTENSIONAHA.114.04117. Epub 2014 Nov 3. Hypertension. 2015. PMID: 25368029 No abstract available.
-
Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up.J Am Heart Assoc. 2015 Dec 23;4(12):e002505. doi: 10.1161/JAHA.115.002505. J Am Heart Assoc. 2015. PMID: 26702078 Free PMC article.
-
[Cardiometabolic and cardiorenal syndromes interactions in Algerian diabetic-hypertensive patient: interest of predictive multi-biomarkers strategy to renal dysfunction].Ann Biol Clin (Paris). 2015 Jul-Aug;73(4):443-53. doi: 10.1684/abc.2015.1059. Ann Biol Clin (Paris). 2015. PMID: 26411911 French.
-
Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.Heart Fail Rev. 2014 Mar;19(2):267-84. doi: 10.1007/s10741-013-9391-x. Heart Fail Rev. 2014. PMID: 23563622 Review.
-
Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease.Clin Chem. 2017 Jan;63(1):108-115. doi: 10.1373/clinchem.2016.262907. Epub 2016 Nov 15. Clin Chem. 2017. PMID: 28062615 Free PMC article. Review.
Cited by
-
Impact of recombinant human brain natriuretic peptide on emergency dialysis and prognosis in end-stage renal disease patients with type 4 cardiorenal syndrome.Sci Rep. 2023 Nov 25;13(1):20752. doi: 10.1038/s41598-023-48125-1. Sci Rep. 2023. PMID: 38007545 Free PMC article.
-
Management of Hypertension With Non-pharmacological Interventions: A Narrative Review.Cureus. 2023 Aug 6;15(8):e43022. doi: 10.7759/cureus.43022. eCollection 2023 Aug. Cureus. 2023. PMID: 37674940 Free PMC article. Review.
-
The spectrum of plasma renin activity and hypertension diseases: Utility, outlook, and suggestions.J Clin Lab Anal. 2022 Nov;36(11):e24738. doi: 10.1002/jcla.24738. Epub 2022 Oct 25. J Clin Lab Anal. 2022. PMID: 36284404 Free PMC article. Review.
-
Serum aldosterone and urine electrolytes dynamics in response to DASH diet intervention - An inpatient mechanistic study.J Clin Transl Sci. 2022 Apr 25;6(1):e84. doi: 10.1017/cts.2022.394. eCollection 2022. J Clin Transl Sci. 2022. PMID: 35949658 Free PMC article.
-
Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States.Biology (Basel). 2022 Jun 3;11(6):859. doi: 10.3390/biology11060859. Biology (Basel). 2022. PMID: 35741380 Free PMC article. Review.
References
-
- Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med. 1992;120:893–901. - PubMed
-
- Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, Fox CS, Meigs JB, Levy D, Larson MG, Selhub J, D’Agostino RB, Sr, Wang TJ, Vasan RS. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: The framingham offspring study. Circulation. 2007;116:984–992. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous